Gene: SBF2
Official Full Name: SET binding factor 2provided by HGNC
Gene Summary: This gene encodes a pseudophosphatase and member of the myotubularin-related protein family. This gene maps within the CMT4B2 candidate region of chromosome 11p15 and mutations in this gene have been associated with Charcot-Marie-Tooth Disease, type 4B2. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25632 | SBF2 Knockout cell line (HeLa) | Human | SBF2 | 1:3~1:6 | Negative | Online Inquiry |
KO25633 | SBF2 Knockout cell line (HCT 116) | Human | SBF2 | 1:2~1:4 | Negative | Online Inquiry |
KO25634 | SBF2 Knockout cell line (HEK293) | Human | SBF2 | 1:3~1:6 | Negative | Online Inquiry |
KO25635 | SBF2 Knockout cell line (A549) | Human | SBF2 | 1:3~1:4 | Negative | Online Inquiry |
SBF2 Gene Knockout Cell Lines are specialized cellular models engineered to ablate the SBF2 gene, a critical gene involved in various biological processes, including cellular signaling and gene expression regulation. By employing the CRISPR-Cas9 gene-editing technology, these knockout cell lines effectively disable the SBF2 gene, allowing researchers to study the resultant phenotypic and biochemical changes in a controlled environment.
The primary function of SBF2 gene knockout cell lines is to facilitate the investigation of SBF2’s role in cellular mechanisms and its implications in various diseases, including cancer and genetic disorders. The knockout model provides researchers a unique platform to explore vital pathways affected by SBF2, thus enabling them to uncover potential therapeutic targets and elucidate complex biological interactions.
The scientific importance of these cell lines lies in their application in both research and clinical settings. Researchers can utilize SBF2 knockout cell lines to conduct gene function studies, drug screening assays, and validation of therapeutic candidates, pushing forward the boundaries of genome research. In clinical settings, understanding the SBF2 gene's role may assist in developing targeted therapies for diseases associated with its dysregulation, offering the potential for personalized medicine strategies.
What sets SBF2 Gene Knockout Cell Lines apart from other knockout models on the market is their high specificity and reliability in reflecting the physiological ramifications of SBF2 loss-of-function. Additionally, they come with user-friendly protocols and robust customer support, ensuring ease of use and reproducibility in experimental setups.
For researchers and clinicians striving for groundbreaking discoveries and enhanced therapeutic strategies, SBF2 Gene Knockout Cell Lines are invaluable tools that bridge the gap between fundamental research and clinical application. Our company has a long-standing commitment to providing high-quality biological products coupled with comprehensive technical support and expertise, ensuring that our customers can achieve their research goals efficiently and effectively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.